Evaluation of the Finnish Diabetes Risk Score as a screening tool for undiagnosed type 2 diabetes and dysglycaemia among early middle-aged adults in a large-scale …

C Mavrogianni, CP Lambrinou, O Androutsos… - Diabetes research and …, 2019 - Elsevier
Aim To assess the diagnostic accuracy of the FINDRISC for undiagnosed type 2 diabetes
mellitus (T2DM) and dysglycaemia (ie the presence of prediabetes or T2DM) among early …

Evaluation of the Finnish Diabetes Risk Score as a screening tool for undiagnosed type 2 diabetes and dysglycaemia among early middle-aged adults in a large-scale …

C Mavrogianni, CP Lambrinou… - DIABETES …, 2019 - biblio.ugent.be
Evaluation of the Finnish Diabetes Risk Score as a screening tool for undiagnosed type 2
diabetes and dysglycaemia among early middle-aged adults in a large-scale European cohort …

Evaluation of the Finnish Diabetes Risk Score as a screening tool for undiagnosed type 2 diabetes and dysglycaemia among early middle-aged adults in a large-scale …

C Mavrogianni, CP Lambrinou… - Diabetes research …, 2019 - pubmed.ncbi.nlm.nih.gov
Aim To assess the diagnostic accuracy of the FINDRISC for undiagnosed type 2 diabetes
mellitus (T2DM) and dysglycaemia (ie the presence of prediabetes or T2DM) among early …

Evaluation of the Finnish Diabetes Risk Score as a screening tool for undiagnosed type 2 diabetes and dysglycaemia among early middle-aged adults in a large-scale …

C Mavrogianni, CP Lambrinou, O Androutsos… - 2019 - julkari.fi
Evaluation of the Finnish Diabetes Risk Score as a screening tool for undiagnosed type 2
diabetes and dysglycaemia among early middle-aged adults in a large-scale European cohort …

Evaluation of the Finnish diabetes risk score as a screening tool for undiagnosed type 2 diabetes and dysglycaemia among early middle-aged adults in a large-scale …

C Mavrogianni, CP Lambrinou, O Androutsos… - 2019 - cabidigitallibrary.org
Aim: To assess the diagnostic accuracy of the FINDRISC for undiagnosed type 2 diabetes
mellitus (T2DM) and dysglycaemia (ie the presence of prediabetes or T2DM) among early …

Evaluation of the Finnish Diabetes Risk Score as a screening tool for undiagnosed type 2 diabetes and dysglycaemia among early middle-aged adults in a large-scale …

C Mavrogianni, CP Lambrinou… - … and Clinical Practice, 2019 - europepmc.org
Aim To assess the diagnostic accuracy of the FINDRISC for undiagnosed type 2 diabetes
mellitus (T2DM) and dysglycaemia (ie the presence of prediabetes or T2DM) among early …

[PDF][PDF] Evaluation of the Finnish Diabetes Risk Score as a screening tool for undiagnosed type 2 diabetes and dysglycaemia among early middle-aged adults in a …

C Mavrogianni, CP Lambrinou, O Androutsos… - core.ac.uk
Aim: To assess the diagnostic accuracy of the FINDRISC for undiagnosed type 2 diabetes
mellitus (T2DM) and dysglycaemia (ie the presence of prediabetes or T2DM) among early …

Evaluation of the Finnish Diabetes Risk Score as a screening tool for undiagnosed type 2 diabetes and dysglycaemia among early middle-aged adults in a large-scale …

C Mavrogianni, O Androutsos, N Huys, G Cardon… - 2019 - zaguan.unizar.es
Aim: To assess the diagnostic accuracy of the FINDRISC for undiagnosed type 2 diabetes
mellitus (T2DM) and dysglycaemia (ie the presence of prediabetes or T2DM) among early …

Evaluation of the Finnish Diabetes Risk Score as a screening tool for undiagnosed type 2 diabetes and dysglycaemia among early middle-aged adults in a large-scale …

C Mavrogianni, CP Lambrinou… - Diabetes …, 2019 - diabetesresearchclinicalpractice …
Aim To assess the diagnostic accuracy of the FINDRISC for undiagnosed type 2 diabetes
mellitus (T2DM) and dysglycaemia (ie the presence of prediabetes or T2DM) among early …

Evaluation of the Finnish Diabetes Risk Score as a screening tool for undiagnosed type 2 diabetes and dysglycaemia among early middle-aged adults in a large-scale …

C Mavrogianni, CP Lambrinou… - Diabetes …, 2019 - diabetesresearchclinicalpractice …
Aim To assess the diagnostic accuracy of the FINDRISC for undiagnosed type 2 diabetes
mellitus (T2DM) and dysglycaemia (ie the presence of prediabetes or T2DM) among early …